Leading Japanese Drug Wholesalers Form Joint Ventures In China
This article was originally published in PharmAsia News
Executive Summary
Two of Japan's leading drug wholesale companies plan to form separate joint ventures in China to gain shares of its huge market. Medicio Paltac Holdings and Mitsubishi plan to expand their three-year-old alliance to China by bringing in a top Chinese drug wholesaler into their joint venture. Toho Pharmaceutical and Jointown Group plan to use their own joint venture to market Japanese drugs to Chinese hospitals and pharmacies. The Japanese firms seek to take advantage of a growing Chinese acceptance of Western medicine in a country that still relies heavily on traditional remedies. (Click here for more - a subscription may be required